Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy

INTRODUCTION: Self-limited infantile epilepsy (SeLIE) is a benign epilepsy. Previous studies have shown that monotherapy with most antiseizure medications can effectively relieve seizures in patients with SeLIE, but the efficacy of levetiracetam has not been investigated. OBJECTIVE: This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yang, Shi, Zhen, Cai, Jiahao, Hou, Chi, Wang, Xiuying, Zhu, Haixia, Peng, Binwei, Shi, Kaili, Li, Xiaojing, Gong, Sitang, Chen, Wen-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601096/
https://www.ncbi.nlm.nih.gov/pubmed/37880614
http://dx.doi.org/10.1186/s12887-023-04212-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601096/
https://www.ncbi.nlm.nih.gov/pubmed/37880614
http://dx.doi.org/10.1186/s12887-023-04212-w

Ejemplares similares